amathy/nice-mnd-sialorrhea
amathy/nice-mnd-sialorrhea
You can alsoView the extension on GitHub
NICE guideline for Motor Neurone Disease: treatment of saliva problems
Developed by: National Institute for Clinical Excellence (NICE)
Description: This guideline the treatment recommendation by NICE in the United Kingdom for the treatment of saliva problems in patients with Motor Neurone Disease. This is under section 1.8 of the guideline
Assessment
- Saliva Issues
- Assess volume and viscosity of saliva.
- Evaluate respiratory function, swallowing, diet, posture, and oral care.
Management
-
Drooling (Sialorrhoea)
- Provide advice on:
- Swallowing
- Diet
- Posture and positioning
- Oral care
- Suctioning
- Provide advice on:
-
First-line Treatment
-
Antimuscarinic Medicine
- Consider a trial for sialorrhoea.
-
Glycopyrrolate
- Preferable for patients with cognitive impairment due to fewer CNS side effects.
-
-
Second-line Treatment
- Botulinum Toxin A
- Refer to a specialist if first-line treatment is ineffective, not tolerated, or contraindicated.
- Botulinum Toxin A
-
Thick, Tenacious Saliva
- Review current medications, especially treatments for sialorrhoea.
- Provide advice on:
- Swallowing
- Diet
- Posture and positioning
- Oral care
- Suctioning
- Consider treatments with:
- Humidification
- Nebulisers
- Carbocisteine
Resources
NICE Motor Neurone Disease guideline: treatment of saliva problems
The clinical flowsheet corresponds to section 1.8.1x of the NICE MND guideline, laying out recommendations for the treatment of saliva problems in patients with MND
View Resource Paper